These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15846457)

  • 61. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
    Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
    J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Chem Biol Drug Des; 2007 Mar; 69(3):204-11. PubMed ID: 17441906
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
    Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
    J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.
    Thorn K; Nielsen CU; Jakobsen P; Steffansen B; Zercher CK; Begtrup M
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4597-601. PubMed ID: 21703856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ligand and structure-based approaches for the identification of SIRT1 activators.
    Vyas VK; Goel A; Ghate M; Patel P
    Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
    Dayam R; Sanchez T; Neamati N
    J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors.
    Wang HY; Cao ZX; Li LL; Jiang PD; Zhao YL; Luo SD; Yang L; Wei YQ; Yang SY
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4972-7. PubMed ID: 18762425
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacophore based virtual screening, synthesis and SAR of novel inhibitors of Mycobacterium sulfotransferase.
    Saha R; Tanwar O; Alam MM; Zaman MS; Khan SA; Akhter M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):701-7. PubMed ID: 25541388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening.
    Dessalew N; Bharatam PV
    Chem Biol Drug Des; 2006 Sep; 68(3):154-65. PubMed ID: 17062013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.
    Kulkarni AA; Davies DL; Links JS; Patel LN; Lee VH; Haworth IS
    Pharm Res; 2007 Jan; 24(1):66-72. PubMed ID: 17009102
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.
    Chapy H; Goracci L; Vayer P; Parmentier Y; Carrupt PA; Declèves X; Scherrmann JM; Cisternino S; Cruciani G
    Br J Pharmacol; 2015 Oct; 172(20):4888-904. PubMed ID: 26220580
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacophore Models Derived From Molecular Dynamics Simulations of Protein-Ligand Complexes: A Case Study.
    Wieder M; Perricone U; Seidel T; Langer T
    Nat Prod Commun; 2016 Oct; 11(10):1499-1504. PubMed ID: 30549607
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.
    Dror O; Shulman-Peleg A; Nussinov R; Wolfson HJ
    Curr Med Chem; 2004 Jan; 11(1):71-90. PubMed ID: 14754427
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing.
    Diao L; Ekins S; Polli JE
    Pharm Res; 2009 Aug; 26(8):1890-900. PubMed ID: 19437106
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    Gandhi T; Melge AR; Gopi Mohan C
    J Adv Res; 2016 Nov; 7(6):931-944. PubMed ID: 27713840
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides.
    Bajraktari-Sylejmani G; von Linde T; Burhenne J; Haefeli WE; Sauter M; Weiss J
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015235
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1.
    Rafiq M; Ernst HA; Aduri NG; Prabhala BK; Tufail S; Rahman M; Bloch MB; Mirza N; Taylor NMI; Boesen T; Gajhede M; Mirza O
    Protein Expr Purif; 2022 Feb; 190():105990. PubMed ID: 34637915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.
    Wei D; Jiang X; Zhou L; Chen J; Chen Z; He C; Yang K; Liu Y; Pei J; Lai L
    J Med Chem; 2008 Dec; 51(24):7882-8. PubMed ID: 19090779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacophore modeling in drug discovery and development: an overview.
    Khedkar SA; Malde AK; Coutinho EC; Srivastava S
    Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Automated pharmacophore identification for large chemical data sets.
    Chen X; Rusinko A; Tropsha A; Young SS
    J Chem Inf Comput Sci; 1999; 39(5):887-96. PubMed ID: 10529987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.